메인메뉴 바로가기

All Menu

About Us Business & Products R&D new products/R&D Plants & Quality Careers News

Hanmi Fine Chemical.Co.,Ltd.

글로벌메뉴

메인메뉴


HomeR&DPipe line

R&D

Pipe line

Pipeline Products of API Research Center

  • Irbesartan

    PPurity of over 99.99%; Particle size of under D50 3㎛; Process validation complete; Commercial production of over 80kg in batch size; Medication for hypertension.

    structural
  • Candesartan Cilexetil

    Purity of over 99.98%; Particle size of under D90 20㎛; Process validation complete; Commercial production of over 20kg in batch size; Medication for hypertension.

    structural
  • Duloxetine

    Purity of over 99.95%; Medication for depression.

    structural
  • Rosuvastatin

    Purity of over 99.95%; Medication for hyperlipidemia; Lab process set up complete.

    structural
  • Raloxifene

    Purity of over 99.95%; Medication for osteoporosis; Lab process set up complete.

    structural
  • Azilsartan

    Purity of over 99.90%; Medication for hypertension; Lab process set up complete.

    structural
  • Celecoxib

    Purity of over 99.90%; Anti-inflammatory agent; Lab process under R&D.

    structural
  • Tenofovir Disoproxil Fumarate.

    Lab process under R&D; Antiviral agent for treating hepatitis B and HIV developed by Glead to which patients won’t develop tolerance and is safe to use by children and pregnant women; API under development as a generic product at Hanmi.

    structural
  • Ezetimibe

    Process Validation completed, Purity is not less than 99.90% APIs for Diabetes.

    structural
  • Bepotastain

    Process set up completed, Purity is not less than 99.90% Antihistamines.

    structural
  • Solifenacin

    High Purity 99.95% APIs for irritable bladder syndrome.

    structural
TOP